by Ryan Michalek | Jul 22, 2022 | Press Releases
Elusys Invited to Present LAV-BASTA-48 Anthrax Vaccine at the Annual Defense Threat Reduction Agency (DTRA) Chemical and Biological Science & Technology Annual Conference Live Attenuated Single-Dose Spore-Based MDR-Anthrax Vaccine elicits protective immunity for...
by Ryan Michalek | Jul 22, 2022 | Press Releases
Elusys Executes Initial Procurement Contract to Deliver ANTHIM® to the Canadian Government New contract marks the first international sale of ANTHIM® PARSIPPANY, N.J., April 27, 2022 – Today Elusys Therapeutics annoucned it has finalized a contract with the Canadian...
